Name
dual oxidase maturation factor 2
MGI ID
MGI:1914061
Synonyms
9030623N16Rik
Nip2
Viability
Embryo viewer
N/A
Significant
Not Significant
Not tested
| Phenotype | System | Allele | Zyg | Sex | Life Stage | P Value |
|---|---|---|---|---|---|---|
| increased mean corpuscular hemoglobin | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.63×10-19 | ||
| decreased erythrocyte cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.01×10-14 | ||
| decreased circulating thyroxine level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased body length | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased leukocyte cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.87×10-22 | ||
| decreased circulating glucose level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 6.29×10-23 | ||
| abnormal joint morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 5.46×10-16 | ||
| abnormal bone structure | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| abnormal zygomatic bone morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.14×10-19 | ||
| decreased effector memory T-helper cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| abnormal radius morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.05×10-16 | ||
| increased total body fat amount | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased circulating cholesterol level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased hematocrit | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 9.81×10-08 | ||
| increased mean corpuscular hemoglobin concentration | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.64×10-07 | ||
| improved glucose tolerance | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.23×10-06 | ||
| decreased red blood cell distribution width | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.03×10-25 | ||
| increased CD8-positive, naive alpha-beta T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| abnormal hair growth | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 4.12×10-07 | ||
| decreased memory-marker gamma-delta T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| absent pinna reflex | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.05×10-18 | ||
| increased circulating serum albumin level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.70×10-09 | ||
| increased circulating HDL cholesterol level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased circulating aspartate transaminase level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 4.32×10-05 | ||
| decreased B cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased bone mineral density | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.72×10-13 | ||
| increased blood urea nitrogen level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.27×10-05 | ||
| decreased B-2 B cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| abnormal auditory brainstem response | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 5.10×10-12 | ||
| abnormal eyelid morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.16×10-07 | ||
| increased effector memory CD8-positive, alpha-beta T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| abnormal cranium morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 2.11×10-12 | ||
| increased circulating fructosamine level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 9.74×10-20 | ||
| abnormal vertebral arch morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.14×10-19 | ||
| abnormal iris morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.49×10-05 | ||
| abnormal thoracic cage shape | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 6.18×10-15 | ||
| decreased follicular B cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| abnormal clavicle morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.18×10-19 | ||
| abnormal femur morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.82×10-17 | ||
| abnormal snout morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 5.11×10-12 | ||
| abnormal vertebrae morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 2.21×10-10 | ||
| decreased KLRG1-positive NK cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased NK cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased heart weight | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.01×10-22 | ||
| decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased alpha-beta T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased lean body mass | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 2.09×10-08 | ||
| decreased CD11b-high dendritic cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased circulating sodium level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.68×10-10 | ||
| increased T-helper cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased Ly6C low monocyte number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| abnormal tibia morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.18×10-19 | ||
| abnormal ulna morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.82×10-17 | ||
| decreased circulating insulin level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.07×10-06 | ||
| decreased circulating amylase level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 3.71×10-06 | ||
| decreased immature B cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased circulating total protein level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 9.30×10-11 | ||
| decreased total body fat amount | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.35×10-12 | ||
| increased neutrophil cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased fasting circulating glucose level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 1.91×10-10 | ||
| increased circulating calcium level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 4.64×10-11 | ||
| thrombocytopenia | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 7.02×10-08 | ||
| increased plasmacytoid dendritic cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased transitional stage T1 B cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased CD4-positive, alpha beta T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased mean platelet volume | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 9.07×10-09 | ||
| decreased hemoglobin content | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 2.40×10-07 | ||
| decreased grip strength | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 4.20×10-26 | ||
| abnormal head morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 6.82×10-06 | ||
| decreased bone mineral content | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased circulating LDL cholesterol level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased circulating iron level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 6.41×10-08 | ||
| decreased CD8-positive, alpha-beta T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| decreased mature B cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased circulating creatinine level | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 6.40×10-16 | ||
| decreased lean body mass | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| increased CD8-positive, alpha-beta T cell number | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 0.00 | ||
| abnormal humerus morphology | Duoxa2tm1b(KOMP)Wtsi | HOM | Early adult | 2.51×10-18 |
Select physiological systems to view:
Viewing: all phenotypes
Select physiological systems to view:
Viewing: all phenotypes
